Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 429

1.

The conservative behavior of dissolved organic carbon in surface waters of the southern Chukchi Sea, Arctic Ocean, during early summer.

Tanaka K, Takesue N, Nishioka J, Kondo Y, Ooki A, Kuma K, Hirawake T, Yamashita Y.

Sci Rep. 2016 Sep 23;6:34123. doi: 10.1038/srep34123.

2.

A high efficient protocol for soybean root transformation by Agrobacterium rhizogenes and most stable reference genes for RT-qPCR analysis.

Kuma KM, Lopes-Caitar VS, Romero CC, Silva SM, Kuwahara MK, Carvalho MC, Abdelnoor RV, Dias WP, Marcelino-GuimarĂ£es FC.

Plant Cell Rep. 2015 Nov;34(11):1987-2000. doi: 10.1007/s00299-015-1845-2. Epub 2015 Aug 1.

PMID:
26232349
3.

Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.

Xiao K, Li YP, Wang C, Ahmad S, Vu M, Kuma K, Cheng YQ, Lam KS.

Biomaterials. 2015 Oct;67:183-93. doi: 10.1016/j.biomaterials.2015.07.033. Epub 2015 Jul 17.

4.

Laterally spreading iron, humic-like dissolved organic matter and nutrients in cold, dense subsurface water of the Arctic Ocean.

Hioki N, Kuma K, Morita Y, Sasayama R, Ooki A, Kondo Y, Obata H, Nishioka J, Yamashita Y, Nishino S, Kikuchi T, Aoyama M.

Sci Rep. 2014 Oct 27;4:6775. doi: 10.1038/srep06775.

5.

Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis.

Yoshitomi R, Nakayama M, Ura Y, Kuma K, Nishimoto H, Fukui A, Ikeda H, Tsuchihashi T, Tsuruya K, Kitazono T.

Hypertens Res. 2014 Dec;37(12):1050-5. doi: 10.1038/hr.2014.120. Epub 2014 Jul 24.

PMID:
25056682
6.

Accumulation of humic-like fluorescent dissolved organic matter in the Japan Sea.

Tanaka K, Kuma K, Hamasaki K, Yamashita Y.

Sci Rep. 2014 Jul 16;4:5292. doi: 10.1038/srep05292.

7.

Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study.

Nakayama M, Kaizu Y, Nagata M, Ura Y, Ikeda H, Shimamoto S, Kuma K.

BMC Nephrol. 2013 Jan 22;14:22. doi: 10.1186/1471-2369-14-22.

8.

[Investigation of actual conditions of mammography in Kagoshima Prefecture].

Baba N, Tanimoto E, Kobayashi Y, Kuma K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009 Nov 20;65(11):1526-33.

9.

Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute.

Kakudo K, Bai Y, Katayama S, Hirokawa M, Ito Y, Miyauchi A, Kuma K.

Pathol Int. 2009 Jun;59(6):359-67. doi: 10.1111/j.1440-1827.2009.02378.x. Review.

PMID:
19490465
10.

A novel homozygous missense mutation of the dual oxidase 2 (DUOX2) gene in an adult patient with large goiter.

Ohye H, Fukata S, Hishinuma A, Kudo T, Nishihara E, Ito M, Kubota S, Amino N, Ieiri T, Kuma K, Miyauchi A.

Thyroid. 2008 May;18(5):561-6. doi: 10.1089/thy.2007.0258.

PMID:
18426362
11.

Ancient divergence of animal protein tyrosine kinase genes demonstrated by a gene family tree including choanoflagellate genes.

Suga H, Sasaki G, Kuma K, Nishiyori H, Hirose N, Su ZH, Iwabe N, Miyata T.

FEBS Lett. 2008 Mar 5;582(5):815-8. doi: 10.1016/j.febslet.2008.02.002. Epub 2008 Feb 11.

12.

A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism.

Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K, Miyauchi A.

Endocr J. 2007 Dec;54(6):927-34. Epub 2007 Nov 16.

13.

The repertoire of desaturases and elongases reveals fatty acid variations in 56 eukaryotic genomes.

Hashimoto K, Yoshizawa AC, Okuda S, Kuma K, Goto S, Kanehisa M.

J Lipid Res. 2008 Jan;49(1):183-91. Epub 2007 Oct 7.

14.
16.

S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma.

Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Kuma K, Miyauchi A.

Anticancer Res. 2007 Jul-Aug;27(4C):2679-83.

17.
18.

Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests.

Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2007 Aug;31(8):1672-6.

PMID:
17571205
19.

Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination.

Ito Y, Hirokawa M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2007 Jul;31(7):1417-24.

PMID:
17534542
20.

Long-term follow-up for patients with papillary thyroid carcinoma treated as benign nodules.

Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

Anticancer Res. 2007 Mar-Apr;27(2):1039-43.

21.

Endemic goiter due to thyroglobulin gene abnormality and social ostracism.

Fukata S, Hishinuma A, Kuma K, Miyauchi A, Sugawara M.

Endocr J. 2007 Jun;54(3):485-6. Epub 2007 Apr 20. No abstract available.

22.

Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.

Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2007 Jun;31(6):1194-201.

PMID:
17431714
23.

High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid.

Ito Y, Motoo Y, Yoshida H, Iovanna JL, Nakamura Y, Kuma K, Miyauchi A.

Pathology. 2006 Dec;38(6):545-7.

PMID:
17393983
24.

Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.

Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K.

World J Surg. 2007 Apr;31(4):838-48.

PMID:
17347900
25.

Benign thyroid teratomas manifest painful cystic and solid composite nodules: three case reports and a review of the literature.

Nishihara E, Miyauchi A, Hirokawa M, Kudo T, Ohye H, Ito M, Kubota S, Fukata S, Amino N, Kuma K.

Endocrine. 2006 Oct;30(2):231-6. Review.

PMID:
17322585
26.

Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma.

Ito Y, Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A, Kuma K, Miyauchi A.

Anticancer Res. 2006 Nov-Dec;26(6B):4391-5.

27.

Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.

Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, Hiraiwa T, Hanafusa T, Takamatsu J, Miyauchi A.

J Clin Endocrinol Metab. 2007 Feb;92(2):608-11. Epub 2006 Dec 5.

PMID:
17148561
28.

[About a safe mammography screening].

Kuma K.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2006 Oct 20;62(10):1385-6. Japanese. No abstract available.

PMID:
17094199
29.

Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.

Ito Y, Yoshida H, Kakudo K, Nakamura Y, Kuma K, Miyauchi A.

Pathology. 2006 Oct;38(5):421-5.

PMID:
17008280
30.

Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe.

Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2006 Oct;30(10):1821-8.

PMID:
16983469
31.

Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient.

Nishihara E, Fukata S, Hishinuma A, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A.

Endocr J. 2006 Dec;53(6):735-40. Epub 2006 Sep 7.

32.

Positive selection in the ComC-ComD system of Streptococcal Species.

Ichihara H, Kuma K, Toh H.

J Bacteriol. 2006 Sep;188(17):6429-34.

33.

Two-day thionamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease.

Kubota S, Ohye H, Yano G, Nishihara E, Kudo T, Ito M, Fukata S, Amino N, Kuma K, Miyauchi A.

Endocr J. 2006 Oct;53(5):603-7. Epub 2006 Aug 8.

34.

Identification of rDNA-specific non-LTR retrotransposons in Cnidaria.

Kojima KK, Kuma K, Toh H, Fujiwara H.

Mol Biol Evol. 2006 Oct;23(10):1984-93. Epub 2006 Jul 26.

PMID:
16870681
35.

Sensitivity and specificity of intraoperative recurrent laryngeal nerve stimulation test for predicting vocal cord palsy after thyroid surgery.

Tomoda C, Hirokawa Y, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2006 Jul;30(7):1230-3.

PMID:
16773263
36.

Delta Np73 expression in thyroid neoplasms originating from follicular cells.

Ito Y, Uramoto H, Funa K, Yoshida H, Jikuzono T, Asahi S, Higashiyama T, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

Pathology. 2006 Jun;38(3):205-9.

PMID:
16753740
37.

Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan.

Hishinuma A, Fukata S, Nishiyama S, Nishi Y, Oh-Ishi M, Murata Y, Ohyama Y, Matsuura N, Kasai K, Harada S, Kitanaka S, Takamatsu J, Kiwaki K, Ohye H, Uruno T, Tomoda C, Tajima T, Kuma K, Miyauchi A, Ieiri T.

J Clin Endocrinol Metab. 2006 Aug;91(8):3100-4. Epub 2006 May 23.

PMID:
16720658
38.

A case of hypothyroid Graves' disease following external radiation therapy to the cervical region.

Nishihara E, Fukata S, Kimura N, Hagihara M, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A.

Endocr J. 2006 Jun;53(3):357-61. Epub 2006 May 20.

39.

Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake.

Hiraiwa T, Ito M, Imagawa A, Takamatsu J, Kuma K, Miyauchi A, Hanafusa T.

J Endocrinol Invest. 2006 Apr;29(4):380-4.

PMID:
16699308
40.
41.

Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis.

Ohye H, Nishihara E, Sasaki I, Kubota S, Fukata S, Amino N, Kuma K, Miyauchi A.

Intern Med. 2006;45(6):385-9. Epub 2006 Apr 17.

42.

Coexistent Anaplastic and Differentiated Thyroid Carcinoma.

Aratake Y, Nomura H, Kotani T, Marutsuka K, Kobayashi K, Kuma K, Miyauchi A, Okayama A, Okayama A.

Am J Clin Pathol. 2006 Mar;125(3):399-406.

PMID:
16613808
43.

Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.

Aratake Y, Nomura H, Kotani T, Marutsuka K, Kobayashi K, Kuma K, Miyauchi A, Okayama A, Tamura K.

Am J Clin Pathol. 2006 Mar;125(3):399-406.

PMID:
16613343
44.

A prophylactic infusion of calcium solution reduces the risk of symptomatic hypocalcemia in patients after total thyroidectomy.

Uruno T, Miyauchi A, Shimizu K, Tomoda C, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Amino N, Kuma K.

World J Surg. 2006 Mar;30(3):304-8.

PMID:
16479342
45.

Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival.

Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2006 May;30(5):780-6.

PMID:
16411013
46.
47.

Computed tomography scan under a trumpet maneuver to demonstrate piriform sinus fistulae in patients with acute suppurative thyroiditis.

Miyauchi A, Tomoda C, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Fukata S, Amino N, Kuma K.

Thyroid. 2005 Dec;15(12):1409-13. No abstract available.

PMID:
16405421
48.
49.

Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years.

Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

Surg Today. 2006;36(1):12-8.

PMID:
16378187
50.

Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid.

Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A.

World J Surg. 2006 Jan;30(1):91-9.

PMID:
16369721

Supplemental Content

Support Center